Premium
Developing an optimal approach to global drug safety
Author(s) -
Balkrishnan R.,
Furberg C. D.
Publication year - 2001
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.2001.00883.x
Subject(s) - medicine , scrutiny , drug reaction , drug , patient safety , postmarketing surveillance , intensive care medicine , medical emergency , pharmacology , adverse effect , political science , health care , law
. Balkrishnan R, Furberg CD (Wake Forest University School of Medicine, Winston‐Salem, NC, USA). Developing an optimal approach to global drug safety (Review). J Intern Med 2001: 250 ; 271–279. An increasing number of media reports on a number of marketed drugs withdrawn because of harmful effects, a scientific report on epidemic proportions of serious adverse drug reactions in hospitalized patients, and a disturbing report on medical mistakes that includes medication errors have recently all brought drug safety into intense focus and placed it under greater scrutiny. Concerted efforts are now being made to understand the causes of drug safety problems and to find ways to reduce their frequency. An international symposium, ‘Developing an Optimal Approach to Drug Safety’ was held at Wake Forest University in the Fall of 2000 to identify the issues and solutions to extant problems in this area. This report summarizes the resulting discussions of global postmarketing surveillance initiatives and describes efforts to reduce medication errors, and improve global communication about drug safety.